Real-time enrollment status for this fibrolamellar hepatocellular carcinoma (flc) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:58 PM UTC
| NCT Number | NCT04248569 |
| Recruiting Status | Recruiting |
| Condition | Fibrolamellar Hepatocellular Carcinoma (FLC) |
| Phase | PHASE1 |
| Target Enrollment | 56 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | December 3, 2025 (Dec 3, 2025) |
As of August 27, 2026: Clinical trial NCT04248569 is currently recruiting participants. This phase1 study for fibrolamellar hepatocellular carcinoma (flc) is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04248569 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04248569 was last updated Dec 3, 2025 (December 3, 2025). HelloStudys verifies this status automatically.